AKT1 and diabetes mellitus: ADAM17 plays a direct role in the pathogenesis of diabetes-associated neurodegenerative processes, including the cell signaling pathways involving both diseases, such as AKT, NF-κB, JAK-STAT, MAPK, and NLRP3 inflammasome pathways.